# Acrivon Therapeutics, Inc. (ACRV): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Acrivon Therapeutics, Inc. (ACRV) is 26/100, ranked against 24,000+ stocks in 35 markets (Quality 28, Value 34, Momentum 49, each scored against its sector).

- StockRank: 26/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 28, Value 34, Momentum 49: each a 0-100 percentile within Healthcare.
- Position: #19,593 overall, #1,724 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 1.72 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 40K.

Source: https://moatmap.ai/stock/ACRV
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker